Pennsylvania Breast Cancer Coalition Research Grants is sponsored by PA Breast Cancer Coalition. The PA Breast Cancer Coalition awards grants to Pennsylvania scientists focused on finding breakthroughs in the detection and treatment of breast cancer.

Pat Halpin-Murphy, President & Founder, PA Breast Cancer Coalition # Request for Application (RFA) # PA Breast Cancer Coalition # Breast and Cervical Cancer Research Initiative # Date of Issuance: March 3 # Letter of Intent due*: April 17, 2026 # Application due*: May 22, 2026 # Grant period: January 1, 2027 - December 31, 2027 *Whether submitted by mail or delivered in person, materials must be received at the Pennsylvania Breast Cancer Coalition Issuing Office address by 4:00 pm EST.

Pennsylvania Breast Cancer Coalition 2397 Quentin Road, Suite B researchgrants@pabreastcancer. org PA Breast Cancer Coalition 2397 Quentin Rd. , Suite B RFA Administrator/Grants Officer: Director of Finance and Administration PA Breast Cancer Coalition 2397 Quentin Rd.

, Suite B tricia@pabreastcancer. org 2 | P a g e # Breast and Cervical Cancer Research Initiative Part One: General Information A. Information for Applicants C.

Application Procedures 2) Evaluation of Applications 5) Reporting Requirements D. Application Instructions and Required Format 1) Application Instructions Part Two: Application Attachments B. Application Cover page C.

Certification for the Protection of Human Subjects, Human Anatomical Substances, Human Cadavers D. Certification for the Containment of Recombinant DNA Research, and the Care and Treatment of Vertebrate Laboratory Animals E. Notice and Payment Provisions F.

Sample Research Grant Agreement Part Three: Standard General Terms and Conditions Part One – General Information A. Information for Applicants Through this RFA process, the Pennsylvania Breast Cancer Coalition (PBCC) is soliciting research applications on breast or cervical cancer from Pennsylvania institutions and organizations.

The PBCC is interested in funding research applications addressing a problem area in either breast or cervical cancer but is not limiting the type of research. The overall goal of this funding is to promote research directed toward reducing the incidence of and mortality associated with breast or cervical cancer. The grant agreement term is January 1, 2027 - December 31, 2027.

3 | P a g e Applications are welcomed from Pennsylvania-based for-profit and nonprofit institutions and organizations in either the public or private sector, such as universities, colleges, hospitals, and laboratories whose application and background show them to be qualified, responsible, and capable of conducting the activities described.

Additional information about how to apply, relevant and specific restrictions, and stated preferences regarding applicants are noted and outlined in Section C, Application Procedures, beginning on page 6 below. This RFA provides interested institutions, organizations, and persons with information to prepare and submit applications to the PBCC.

Questions about this RFA can be directed to Diane Funston, RFA Project Officer, PA Breast Cancer Coalition at Diane@PABreastCancer. org. The applicant must submit a Letter of Intent, using the form Attachment A, stating that they intend to apply for the grant.

Letters of Intent must be received at researchgrants@pabreastcancer. org by 4:00 pm Any agreement resulting from this RFA will include certain standard general terms and conditions. Please have your facility’s legal counsel review ATTACHMENT F: RESEARCH GRANT AGREEMENT which is included with this application PRIOR TO APPLYING.

These terms are non-negotiable. If your facility cannot comply with these terms DO NOT APPLY. Please fill out the following form and return it by email to researchgrants@PABreastCancer.

org .

4 | P a g e ATTACHMENT A: Letter of Intent PA Breast Cancer Coalition Breast and Cervical Cancer Research Initiative RFA: 2027 Due Date: April 17, 2026* Topic Area (please select) : Breast Cancer or Cervical Cancer Title of Project: _____________________________________________________________________________ Principal Investigator: _______________________________________________________________________ Telephone #: ________________________ Email: _________________________________________________ Mailing Address (The address where you would like notification about this application to be sent) : ___________________________________________________________________________________________ ___________________________________________________________________________________________ Collaborator 1 (if applicable) __________________________________________________________________ Telephone #: ________________________ Email: _________________________________________________ Collaborator 2 (if applicable) __________________________________________________________________ Telephone #: ________________________ Email: _________________________________________________ PI Organization or Institution Name: __________________________________________________________ Type of Legal Entity: ________________________________________________________________________ If tax-exempt please indicate IRC Section (i.e., 501(c) (3): __________________________________________ Federal I.

D.

#: ______________________________________________________________________________ Address: ___________________________________________________________________________________ ___________________________________________________________________________________ City: ____________________________________ State: ________________ Zip Code: ___________________ Grant Office Contact Person:__________________________________________________________________ Telephone #: ______________________Fax: __________________Email:________________________ > Any agreement resulting from this RFA will include standard terms and conditions.

Our facility and legal counsel have reviewed ATTACHMENT F: RESEARCH GRANT AGREEMENT and agree to the contract terms. > Signature of Researcher > Print/Type Name Print/Type Title > Signature of Representative from the Facility’s Grant Department > Print/Type Name Print/Type Title C. Application Procedures a) Letters of Intent due April 17, 2026*.

b) Full applications due May 22, 2026*. *Materials must be received by the PBCC at researchgrants@pabreastcancer. org by c) If it becomes necessary to revise any part of the application guidelines, an amendment will be posted on the PBCC website, www.

PABreastCancer. org . d) The decision of the PBCC with regard to selection of applicants is final.

The PBCC reserves the right to reject any and all applications received as a result of this request and to negotiate separately with competing applicants. e) Contractors whose applications are selected are not permitted to issue news releases pertaining to this project prior to official written notification of the award by the PBCC.

Any subsequent publication or media release issued by the Contractor throughout the life of the grant using funding from this grant must acknowledge the PBCC as the granting agency. f) Applicants may submit more than one research application; however, only one award per principal investigator shall be made during any funding cycle. g) Applications are initiated by individuals but must be formally submitted by their institutions.

Awards shall be made to institutions and organizations, not individuals. h) Any agreement resulting from this RFA will include certain standard general terms and conditions. Please have your facility’s legal counsel review ATTACHMENT F: RESEARCH GRANT AGREEMENT which is included with this application PRIOR TO APPLYING.

These terms are non-negotiable. If your facility cannot comply with all of these terms DO NOT APPLY. 2.

Review of Applications Process and Evaluation of Applications: a) All applications meeting stated requirements in this RFA and received by the designated date and time will be reviewed. b) The applications will be reviewed by the PA Breast and Cervical Cancer Research Initiative Review Committee (Review Committee), consisting of qualified personnel selected by the PBCC.

c) The Review Committee will recommend applications for funding that most closely meet the evaluation criteria developed by the PBCC. d) If the Review Committee needs additional clarification of an application, PBCC staff may schedule an oral presentation and/or request written clarification and assign a due date for the submission of such written clarification.

6 | P a g e e) Evaluation criteria used by the Review Committee include: Scientific Relevance, Impact, and Innovation: The application must address a critical problem or innovative issue in breast or cervical cancer research. The study should, if successful, advance knowledge toward the goal of reducing breast or cervical cancer incidence and mortality. The proposed research should add to current knowledge in breast or cervical cancer.

The application should address the likelihood that funding from the PA Breast and Cervical Cancer Research Initiative would lead to subsequent success in achieving funding from a national organization. Principal Investigator (PI): The application must address the representation from all the areas of expertise needed to conduct the study successfully.

The application shall show that the PI and other researchers (if any) are appropriately trained and well suited to carry out this work. Feasibility and Timelines: The applicant must articulate a clear plan for what shall be accomplished, including a step-by-step plan with timelines for accomplishing the specific tasks. The application should indicate that the objectives shall be met within the time frame.

Budget: The budget must be reasonable for the work proposed. 7 | P a g e Grants will be administered through the PBCC. The maximum grant award per research application is $100,000.

Indirect costs (overhead, general, administrative, and other) may not be billed . All applicants will receive official written notification of the status of their application from the PBCC. All applicants may request a final report showing the strengths and weaknesses of their application.

This request must be in writing and must be received by the PBCC within 30 calendar days of the date of the PBCC’s written notification of the status of the application. A comparison of applications will not be provided. a) The Contractor may be required to present an oral report to the PBCC or the PA Breast and Cervical Cancer Research Initiative Review Committee at any time between the end of the grant period and six months following.

b) The Contractor is encouraged to publish their results in scientific literature. The Contractor will submit a copy of any manuscript or publications resulting from their research to the PBCC. The Contractor will include the following statement on printed materials resulting from funded research: “This project is funded, in part, by the Pennsylvania Breast Cancer Coalition.

The PBCC takes no part in and is in no way responsible for any analyses, interpretations, or conclusions. ” 5. Reporting Requirements a) The Contractor must request and receive written approval from the PBCC prior to making any changes in key project personnel.

b) Any changes to the budget, scope, or methodology of the research during the term of the grant agreement must be requested in writing and approved in writing by the PBCC prior to implementation. A. The Contractor will submit the following reports: 1.

A Midterm Report on or before the 6th month after the beginning of the grant period which shall be a narrative, not to exceed two (2) pages, summarizing the results of the research to that date. 2.

A Final Report on or before the 13th month after the beginning of the grant period which shall be in the following form: Part #1: A narrative, not to exceed three (3) pages, summarizing the results of the research, specify plans for Scholarly Publications or presentations, and provide answers to the following questions: (i) Was the research successful? (ii) What are the next steps?

(iii)Where does the researcher stand with previous grant applications or any other application(s) that would be relevant? Part #2: Summary and copies of scholarly publications or presentations resulting from or related to this research grant. 8 | P a g e 6.

Additional Grant Requirements a) The Contractor will not make any announcement(s) about PBCC research grant funding prior to the official grant announcement from the PBCC. b) The Contractor will agree to hold a publicity event at their facility between the 1 st month and the 6 th month of grant period or a date designated by the PBCC with the support of the PBCC to publicize the grant and publicly recognize the researcher.

PBCC staff will work with key facility staff to organize the event. D. Application Instructions and Required Format 1.

Application Instructions The applicant must complete and submit the attached Letter of Intent form stating that they intend to apply for the grant. Letters of Intent must be received by the PBCC at researchgrants@pabreastcancer. org by 4:00 pm EST on April 17, 2026.

The application must be received by the PBCC at researchgrants@pabreastcancer. org by 4:00 pm EST on May 22, 2026. (Late applications will be rejected, regardless of the reason).

The application must be submitted using the format described in Subsection 2, below – Application Format. The Certifications Form must be completed and signed by an official authorized to bind the organization to the application. Applicants are to be brief and clear in the presentation of ideas.

Applicants must follow the format as described below to complete the application. Applications must be typewritten on 8 ½'' by 11'' paper, with a font size no smaller than 12 point and margins of at least . 5 inch.

Please use Times New Roman font. a) Cover Page – Complete the form on pages 10-11. b) Certification for the Protection of Human Subjects, Human Anatomical Substances, Human Cadavers – All Applications involving human subjects, human anatomical substances, and human cadavers must be reviewed and approved by the applicant’s appropriate institutional review board (IRB) or biosafety committee prior to the initiation of any research.

Applications will be rejected if the Certification, found in this RFA at page 12, is not completed, signed by the authorized institutional official, and included with the grant application.

c) Containment of Recombinant DNA Research, and the Care and Treatment of Laboratory Animals – All Applications involving laboratory animals or recombinant DNA must be reviewed and approved by the applicant’s appropriate institutional review board, biosafety committee, or animal care and use committee prior to the initiation of any research. Specific documents will be required relating to the use of animals in the proposed research.

Applications will be rejected if the Certification, found in this RFA at page 13, is not completed, signed by the authorized institutional health official, and included with the grant application.

9 | P a g e d) Notice and Payment Provisions – Applicants must provide contact information for the person within their institution who is authorized to receive Notices from PBCC regarding the grant and contact information for the person authorized to receive periodic grant payments. The Notice and Payment Provision form, found in this RFA at page 14, must be completed and attached to the application.

e) Research Description – Provide a narrative description of the proposed methodology addressing the following topics: Summary: The Application Summary should not exceed two (2) pages and must include the following: • Brief summary of experimental or research design • Outline of anticipated results • Relevance and impact of project Work Statement: The work statement should not exceed eight (8) pages and must include the following: • Background statement of problem, including hypothesis to be tested, aims and objectives • Research or experimental design • Statement of work, including lists of tasks to be performed and timeline associated f) Researcher Qualifications – Provide a narrative description of the staff (including qualifications, classifications, whether they are professional, technical, consultant, subcontractor, volunteer, etc.), and identify key personnel who shall be engaged in the research.

Include a biographical sketch or curriculum vitae of each staff person, with the exception of support staff. These pages are not counted in the page limit of this application. g) Budget – Use the downloadable format to present the budget request.

The budget forms can be found at pbcc. me/RFA . The anticipated grant agreement term is January 1, 2027 – December 31, 2027.

The overall 12-month budget for the application shall not exceed $100,000. The budget must contain an overall summary and details for each budget category. Please see budget worksheets and definitions for more information.

h) Completed W-9 form – Provide a copy of the completed Internal Revenue Service form W-9. The W-9 form and instructions for completing the form are available at the website http://www. irs.

gov .

10 | P a g e ATTACHMENT B: APPLICATION COVER PAGE PA Breast Cancer Coalition Breast and Cervical Cancer Research Initiative RFA: 2027 Principal Investigator (PI):_________________________________________________________________________ Co- Investigator (Co-PI)*:___________________________________________________________________ *if applicable Office Telephone #: ______________________________ Cell Phone#: ______________________________________ E-mail:___________________________________________________________________________________________ Mailing Address: (The address where you would like notification about this application to be sent.)

________________________________________________________________________________________________ _________________________________________________________________________________________________ Title of Project: _______________________________________________________________________________ Topic Area (please select) : ___ Breast Cancer or ___ Cervical Cancer PI Organization or Institution Name: _________________________________________________________________ Type of Legal Entity:_______________________________________________________________________ _______ _ If tax-exempt please list IRC Section (i.e. 501(c)(3): _____________________________________________________ Federal I.

D.

#: _____________________________________________________________________________________ Address:__________________________________________________________________________________________ __________________________________________________________________________________________ City:____________________________________________ State: ___________ Zip Code:____________________ Grant Office Contact Person:________________________________________________________________________ Telephone #: ______________________________ E-mail:________________________________________________ 11 | P a g e ATTACHMENT B: APPLICATION COVER PAGE- Page 2 PA Breast Cancer Coalition Breast and Cervical Cancer Research Initiative RFA: 2027 • In order to be reviewed, applications must contain all items, including certifications and agreements that are required in the Request for Application (RFA).

• Submit all application files electronically to researchgrants@pabreastcancer.

org by 4:00 pm EST on May • Please check to confirm that you have submitted the following: Submitted to the PBCC by 4:00 pm EST on April 17, 2026 ___ Cover Page (2-page document) ___ Researcher Qualifications and Key Personnel List ___ Attachment B: Cover Page ___ Attachment C: Certification for the Protection of Human Subjects, Human Anatomical Substances, Human Cadavers ___ Attachment D: Certification for the Containment of Recombinant DNA Research, and the Care and Treatment of Vertebrate Laboratory Animals ___ Attachment E: Notice and Payment Provisions ___ Our facility and legal counsel have reviewed ATTACHMENT F: RESEARCH GRANT AGREEMENT and agree to the contract terms.

___ If this grant application is awarded and if PBCC requests, the Applicant Organization/Institution agrees to hold an event at their facility with the PBCC between the 1 st month and 6 th month of the grant period to publicize the grant and publicly recognize the researcher. PBCC staff will work with key organization/institution staff to organize and publicize this event.

12 | P a g e ATTACHMENT C: CERTIFICATION FOR THE PROTECTION OF HUMAN SUBJECTS, HUMAN ANATOMICAL SUBSTANCES, HUMAN CADAVERS > PRINCIPAL INVESTIGATOR NAME PRINCIPAL INVESTIGATOR TITLE > TITLE OF RESEARCH PROJECT INSTITUTION CERTIFICATION FOR THE PROTECTION OF HUMAN SUBJECTS, HUMAN ANATOMICAL SUBSTANCES, HUMAN CADAVERS It is the responsibility of the research institution to assure that the rights and welfare of all human subjects used in any PA Breast Cancer Coalition sponsored research are protected.

Any research involving human subjects must be reviewed and approved by an appropriate institutional review board. The applicant agrees to safeguard the rights and welfare of individuals who participate in research activities.

The applicant agrees that all experimentation with human subjects shall be prohibited unless the applicant certifies that the prior written approval of its Institutional Review Board (IRB) is obtained or is not required, subject to all applicable laws, including but not limited to 42 U.S.C. Section 3515 (b) (relating to prohibitions on funding certain experiments involving human participants) and the regulations there under.

Further, the prior, written, voluntary, informed consent of each subject must be obtained. If the subject is a minor, or incompetent, the prior, written, voluntary, informed consent of their legal guardian shall be required.

The applicant shall inform each potential subject prior to their consent that refusal shall not result in the loss of any benefits to which the subject is otherwise entitled from the federal government, the Commonwealth, the applicant, any subcontractor of the applicant, or any third party insurer.

Please check the appropriate statement: ___ No human subjects, human anatomical substances or human cadavers will be used in any of the proposed research. ___ Human subjects, human anatomical substances or human cadavers will be used in the proposed research.

This is to certify that the proposed activities on human subjects have been reviewed by an institutional review board (IRB) on _______________ (date) and found to be in accordance with current Department of Health and Human Services (DHHS) policy. ___ This research involves the use of human subjects, human anatomical substances or human cadavers.

This is to certify that the proposed activities involving human subjects have NOT yet been reviewed by an institutional review board (IRB), and that prior to the initiation of research involving human subjects and the use of grant funds to pay for any of the research expenses, the applicant will send documentation to the PBCC that the proposed activities have been reviewed by its institutional review board (IRB) and have been found to be in accordance with current Department of Health and Human Services (DHHS) policy.

> NAME OF AUTHORIZED INSTITUTIONAL OFFICIAL TITLE ATTACHMENT D: CERTIFICATION FOR THE CONTAINMENT OF RECOMBINANT DNA RESEARCH, > PRINCIPAL INVESTIGATOR NAME TITLE OF PRINCIPAL INVESTIGATOR > TITLE OF RESEARCH PROJECT INSTITUTION It is the responsibility of the research institution to assure that the physical and biological containment needed for research involving any recombinant DNA molecules is within policies set out in the current "National Institutes of Health (NIH) Guidelines for Research Involving Recombinant DNA Molecules."

Please check the appropriate statement: ___ This research does not involve any use of recombinant DNA molecules as defined by current NIH guidelines. ___ This research involves the use of recombinant DNA molecules as defined by current NIH guidelines.

This is to certify that the proposed activities involving recombinant DNA molecules have been reviewed by an institutional biosafety committee on _______________ (date) and found to be in accordance with current NIH guidelines. ___ This research involves the use of recombinant DNA molecules as defined by current NIH guidelines.

This is to certify that the proposed activities involving recombinant DNA molecules have NOT yet been reviewed by an institutional biosafety committee, and that prior to the initiation of research involving recombinant DNA and the use of grant funds to pay for any of the research expenses, the applicant will send documentation to the PBCC that the proposed activities have been reviewed by its institutional biosafety committee and found in accordance with current NIH guidelines.

It is the responsibility of the research institution to assure proper care and treatment of all vertebrate laboratory animals used in any PA Breast Cancer Coalition sponsored research. Any research involving laboratory animals must be reviewed and approved by an appropriate Institutional Animal Care and Use Committee (IACUC).

Please check the appropriate statement: ___ No vertebrate laboratory animals will be used in any of the proposed research. ___ Vertebrate laboratory animals will be used in the proposed research. This is to certify that the proposed activities involving laboratory animals have been approved by an institutional animal care and use committee on _________(date) and found to be in accordance with current Public Health Service policy.

___ Vertebrate laboratory animals will be used in the proposed research.

This is to certify that the proposed activities involving laboratory animals have NOT yet been approved by an appropriate IACUC, and that prior to the initiation of research involving vertebrate animals and the use of grant funds to pay for any of the research expenses, the applicant will send documentation to the PBCC that the proposed activities have been reviewed by an appropriate IACUC, and found to be in accordance with current Public Health Service policy.

> NAME OF AUTHORIZED INSTITUTIONAL OFFICIAL TITLE ATTACHMENT E: NOTICE AND PAYMENT PROVISIONS The following individual is authorized to receive all Notices from the PBCC pertaining to this grant: Grant payments should be made to the following: ATTACHMENT F: SAMPLE RESEARCH GRANT AGREEMENT WHEREAS , The Pennsylvania Breast Cancer Coalition (PBCC) has solicited applications for research grants to fund research relating to breast or cervical cancer from institutions and organizations based in Pennsylvania.

WHEREAS, Contractor, named below, a qualifying Pennsylvania institution or organization, has submitted a research application to the PBCC that addresses these research areas.

NOW, THEREFORE , in consideration of the covenants, warranties and representations set forth below, the PBCC and _____________________________________________________, Contractor, intending to be legally bound agrees as follows: Unless otherwise noted in this Agreement the terms shall have the following meanings: Agreement: the terms and conditions of this document, any subsequent grant contracts awarded by the PBCC to Contractor that are solely related to the Scope of Work, the Statement of Work and the Research Application of Contractor.

Background Material: original work papers, notes and drafts prepared by or for Contractor to support conclusions in any final report or product delivered under this Agreement, including but not limited to completed questionnaires and material in electronic data processing form, computer programs and other tangible materials produced by or for Contractor during the term of this Agreement and directly related to the services being rendered.

It does not include Contractor’s financial reports or other information incidental to the administration of this Agreement.

Contractor: _____________________________________________________________________________________ Data: includes, but is not limited to, written reports and analyses, diagrams, maps, system designs, computer programs, flow charts, punched card decks, magnetic tapes, diskettes, drawings, studies, manuals, brochures, advertisements, documents, sketches, papers, files, information, computer documentation, other tangible materials and work of any similar nature which is required to be performed by or for Contractor under this Agreement or which is incidentally prepared by or for Contractor in the performance of this Agreement.

Data also includes Background Material prepared by or for Contractor incidental to the performance of this Agreement. Grant: the award of funds made by the PBCC as in this Agreement. Grant Period: the duration of this Agreement, which shall commence on January 1, 2027 and end December 31, 2027 or as extended in accordance to this Agreement.

Grant Proposal: the proposal submitted by Contractor attached hereto as Exhibit A and incorporated as if fully set forth herein. Key Personnel: the primary investigator or other participants as set forth in Exhibit A who are considered essential to the research being performed under this Agreement.

Pre-Existing Material: intellectual property that Contractor, prior to the grant period, had developed independently or developed with or obtained from third Parties, including but not limited to, background material, proprietary materials, data, software and methodologies. Project or Contracting Officer: PBCC personnel as identified by the PBCC.

16 | P a g e Records: books, documents, sub-contracts and other evidence pertaining to Contractor’s costs and expenses in performance of this Agreement. Research or Research application: the work, investigation, and/or scientific study, to be conducted in accordance with the grant proposal, Exhibit A, and this Agreement.

Researcher: the person designated in the grant proposal and Exhibit A as the primary investigator responsible for conduct of the research subject to this grant.

Scholarly Publication or Presentation: any academic article, abstract, research report, manuscript or presentation that is submitted for peer-review or review by other scholars, experts, or researchers or in any academic or professional meeting or setting resulting from or related to this Grant.

Scope or Statement of Work: any and all research and obligations undertaken or to be performed by Contractor pursuant to this Agreement as set forth in Contractor’s research application or as subsequently modified upon prior approval of PBCC and in agreement with the Contractor. SECTION 2: CONTRACTOR, CONTRACTOR’S OBLIGATIONS 2.

1 INDEPENDENT CONTRACTOR: Contractor shall perform its services under this Agreement as an independent Contractor and shall maintain in full force and effect insurance coverage in amounts required by applicable law and otherwise consistent with commercially reasonable industry standards, including specifically, without limitation, commercial general liability coverage insuring against claims which may arise out of Contractor’s performance under the terms of this Agreement.

Upon request by PBCC, Contractor shall provide PBCC with a certificate of insurance verifying the above-required coverage. Contractor shall notify PBCC at least thirty (30) days prior to the cancellation, reduction, or material change in such coverage.

Contractor shall be responsible for workers’ compensation, social security, income tax deductions, and any other taxes or payroll deductions required by law for its employees who are performing services under this Agreement. 2. 2 KEY PERSONNEL AND PROJECT CHANGES A.

No diversion or removal of Key Personnel shall be made by Contractor without the prior written consent of the Project Officer. B. Contractor shall provide written notice to the PBCC within 30 (thirty) days of any Key Personnel dissociating or being disassociated from Contractor, whether permanently or temporarily.

The PBCC reserves the right upon such event to terminate this Agreement at the PBCC’s sole discretion. C.

No Key Personnel performing research funded pursuant to this Agreement, nor any officer, member or employee of Contractor who exercises any functions or responsibilities under this Agreement, shall participate in any decision relating to this Agreement which affects that person’s personal interest or the interest of any corporation, partnership, or association in which that person is, directly or indirectly, interested.

Contractor further covenants that in the performance of this Agreement, it shall not knowingly employ any person having such interest. D. In addition to the notice relating to Key Personnel above Contractor will notify the PBCC 30 days in advance of and must receive prior written approval for any other proposed changes to the personnel, design, budget, content or specific aims of the Research.

E. The PBCC will be provided a minimum of 14 days to review and accept or reject any such proposed changes and will provide Contractor with a decision in writing after review. F.

Notwithstanding the above, Contractor may modify the budget or this research without prior approval of the PBCC if the modification does not (i) change any budget expense subcategory by more than 5%; (ii) increase 17 | P a g e the amount of any cost above the maximum allowable for a subcategory item; or (iii) result in an expenditure beyond the Grant. A.

Contractor may not assign whole or in part or its rights, duties, obligations or responsibilities under this Agreement without the prior written consent of PBCC, which consent may be withheld at the sole and absolute discretion of PBCC. B.

Any assignment consented to by PBCC shall be in writing executed by Contractor and its assignee in which the assignee agrees to be legally bound by all of the terms and conditions of this Agreement and to assume the duties, obligations, and responsibilities being assigned. C.

Notwithstanding the foregoing, Contractor may, without the consent of the PBCC, assign its rights to payments to be received under this Agreement, provided that Contractor provides written notice of such assignment to the PBCC together with a written acknowledgment from the assignee that any such payments are subject to all of the terms and conditions of this Agreement. A.

Except for sub-contracts specifically authorized by this Agreement, Contractor shall not enter into sub-contracts for any of the work contemplated under this Agreement without obtaining prior written approval of the PBCC, which shall be attached to this Agreement, subject to such conditions and provisions as the PBCC may deem necessary. B.

Notwithstanding the foregoing, unless otherwise provided herein, such prior written approval shall not be required for the purchase by Contractor of articles, supplies, equipment and services which are both necessary for and merely incidental to the performance of the Research required under this Agreement. C.

Approval by the PBCC of any sub-contract, shall not be deemed to provide for the incurrence of any obligation or liability on the part of the PBCC with regard to any sub-contract entered into by Contractor. A. The PBCC shall have no ownership rights to